Reported 2026-06-07Lot GLOW-062026-499.68% purity · GHK-Cu - 59.92 mg, BPC-157 - 10.86 mg, Thymosin Beta-4 - 11.71 mg
Open COA
Lyophilized Peptides
GHK-CU/BPC-157/TB-500 GLOW Blend
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatalogGLOW-PW-50MG-10MG-10MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$115.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
17982 in stock
Current product record, labeling and lot documentation control intended use and handling.
GHK-CU/BPC-157/TB-500 GLOW Blend$115.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
6 approved certificates are attached to this product record.
Reported 2026-06-01Lot GLOW-0621026-199.78% purity · GHK-Cu - 58.32 mg, BPC-157 - 12.19 mg, Thymosin Beta-4 - 12.19 mg
Open COA
Reported 2026-05-01Lot GLOW1200-042026-199.83% purity · GHK-Cu – 991.65 mg, BPC-157 – 94.51 mg, Thymosin Beta-4 – 93.61 mg
Open COA
Reported 2025-12-29Lot GLOW250818-H99.685% purity · GHK-Cu - 50.32 mg, BPC-157 - 13.27 mg, Thymosin Beta-4 - 11.16 mg
Open COA
Reported 2025-07-27Lot GLOW07232025-0399.43% purity · GHK-Cu: 48.50 mg, BPC-157: 13.78 mg, Thymosin Beta-4: 11.48 mg
Open COA
Reported 2025-06-14Lot 0-GLOW-2025061099.75% purity · GHK-Cu: 67.68 mg, BPC-157: 11.74 mg, Thymosin Beta4: 9.19 mg
Open COA
Technical information
Record at a glance
- Primary catalog
- Lyophilized Peptides
- Product type
- Simple product
- Availability
- Available
- Lot control
- Current lot documentation and approved product record control
- Catalog number
- GLOW-PW-50MG-10MG-10MG
Intended laboratory context
Illustrative applications
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Documentation package
Documentation
- PDFCertificate of Analysis / lot recordSample
- PDFProduct data or handling recordSample
- PDFSupporting product media archiveSample
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
Need a current record?
Documentation before decision-making.
Reference GLOW-PW-50MG-10MG-10MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model